Drug News & Perspectives

596 papers and 11.9k indexed citations i.

About

The 596 papers published in Drug News & Perspectives in the last decades have received a total of 11.9k indexed citations. Papers published in Drug News & Perspectives usually cover Molecular Biology (235 papers), Physiology (88 papers) and Immunology (79 papers) specifically the topics of Receptor Mechanisms and Signaling (30 papers), Virus-based gene therapy research (27 papers) and Neuropeptides and Animal Physiology (24 papers). The most active scholars publishing in Drug News & Perspectives are Edward Tobinick, Gaetano Romano, Bruce R. Troen, Chris G. Parsons, G. Quack, Wojciech Danysz, Timothy C. Nichols, Santosh R. D’Mello, B.B. Fredholm and Masaharu Takigawa.

In The Last Decade

Fields of papers published in Drug News & Perspectives

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers published in Drug News & Perspectives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers published in Drug News & Perspectives.

Countries where authors publish in Drug News & Perspectives

Since Specialization
Citations

This map shows the geographic impact of research published in Drug News & Perspectives. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by papers published in Drug News & Perspectives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Drug News & Perspectives more than expected).

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar’s output or impact.

Explore journals with similar magnitude of impact

Rankless by CCL
2025